QSAR Studies of Non-Nucleoside Reverse Transcriptase Inhibitors: The Hydrophobic Effect

被引:1
|
作者
Douali, L. [1 ]
Cherqaoui, D. [1 ]
机构
[1] Univ Cadi Ayyad, Dept Chim, Fac Sci Semlalia, Marrakech, Morocco
关键词
QSAR; hydrophobicity; non-linear; neural networks; anti-HIV; NNRTIs; HEPT; TIBO;
D O I
10.2174/157340906776056446
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are promising compounds in the search for potent and selective drugs for the treatment of AIDS. Although they are structurally diverse, the NNRTIs exhibit a striking similarity in their mode of action on the reverse transcriptase (RT) hydrophobic pocket. Several quantitative structure-activity relationship (QSAR) studies have been devoted to the HEPT and TIBO derivatives acting as NNRTIs. Thanks to their ability to perform non-linear mapping of the physicochemical descriptors to the corresponding biological activity, neural networks (NNs) proved to be a powerful QSAR modeling technique for this series of inhibitors. They show the importance of hydrophobic character of these compounds in their anti-HIV activity variation. One of the purposes of QSAR analyses is to understand the forces governing the activity of a particular class of compounds and to assist drug design. The present work rationalizes in depth the relationship between the hydrophobic character of NNRTIs and their anti-HIV activity. The variation of anti-HIV activity with respect to the hydrophobic parameters is performed by means of NNs and its non-linear aspect is discussed. There is a similarity in the hydrophobic character of TIBO and HEPT derivatives.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 50 条
  • [1] QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Duchowicz, Pablo R.
    Fernandez, Michael
    Caballero, Julio
    Castro, Eduardo A.
    Fernandez, Francisco M.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (17) : 5876 - 5889
  • [2] Non-nucleoside reverse transcriptase (NNRTI) inhibitors
    不详
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (14) : 747 - 748
  • [3] Non-nucleoside reverse transcriptase inhibitors: a review
    Waters, L.
    John, L.
    Nelson, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (01) : 105 - 118
  • [4] Non-nucleoside reverse transcriptase inhibitors pharmacology
    Garrafo, R.
    [J]. VIROLOGIE, 2008, 12 : S15 - S28
  • [5] 3D QSAR Studies of DAMNI Analogs as Possible Non-nucleoside Reverse Transcriptase Inhibitors
    Ganguly, S.
    Gopalakrishnan, V.
    [J]. E-JOURNAL OF CHEMISTRY, 2008, 5 : 1103 - 1113
  • [6] Exploring QSAR of non-nucleoside reverse transcriptase inhibitors by neural networks: TIBO derivatives
    Douali, L
    Villemin, D
    Cherqaoui, D
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2004, 5 (02): : 48 - 55
  • [7] The flourishing syntheses of non-nucleoside reverse transcriptase inhibitors
    Pedersen, OS
    Pedersen, EB
    [J]. SYNTHESIS-STUTTGART, 2000, (04): : 479 - 495
  • [8] Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors
    Patrick F. Smith
    Robert DiCenzo
    Gene D. Morse
    [J]. Clinical Pharmacokinetics, 2001, 40 : 893 - 905
  • [9] Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors
    Smith, PF
    DiCenzo, R
    Morse, GD
    [J]. CLINICAL PHARMACOKINETICS, 2001, 40 (12) : 893 - 905
  • [10] Etravirine: the renaissance of non-nucleoside reverse transcriptase inhibitors
    Jayaweera, Dushyantha T.
    Espinoza, Luis
    Castro, Jose
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (17) : 3083 - 3094